High Expression of Antiviral and Vitamin D Pathway Genes are a Natural Characteristic of a Small Cohort of HIV-1-Exposed Seronegative Individuals
ABSTRACT: Natural resistance to HIV-1 infection is influenced by genetics, viral-exposure, and endogenous immunomodulators such as vitamin D (VitD), being a multifactorial phenomenon that characterizes HIV-1-exposed seronegative individuals (HESNs). We compared mRNA expression of 10 antivirals, 5 im...
- Autores:
-
Aguilar Jimenez, Wbeimar
Saulle, Irma
Trabattoni, Daria
Vichi, Francesca
Lo Caputo, Sergio
Mazzotta, Francesco
Rugeles López, María Teresa
Biasin, Mara
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2017
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/34081
- Acceso en línea:
- https://hdl.handle.net/10495/34081
https://www.frontiersin.org/articles/10.3389/fimmu.2017.00136/full
- Palabra clave:
- VIH-1
HIV-1
Vitamina D
Vitamin D
Antivirales
Antiviral Agents
Inmunidad Innata
Immunity, Innate
HIV Seropositivity
Seropositividad para VIH
- Rights
- openAccess
- License
- http://creativecommons.org/licenses/by/2.5/co/
| id |
UDEA2_a478a50056a6657935aa41cbe7dbbdcf |
|---|---|
| oai_identifier_str |
oai:bibliotecadigital.udea.edu.co:10495/34081 |
| network_acronym_str |
UDEA2 |
| network_name_str |
Repositorio UdeA |
| repository_id_str |
|
| dc.title.spa.fl_str_mv |
High Expression of Antiviral and Vitamin D Pathway Genes are a Natural Characteristic of a Small Cohort of HIV-1-Exposed Seronegative Individuals |
| title |
High Expression of Antiviral and Vitamin D Pathway Genes are a Natural Characteristic of a Small Cohort of HIV-1-Exposed Seronegative Individuals |
| spellingShingle |
High Expression of Antiviral and Vitamin D Pathway Genes are a Natural Characteristic of a Small Cohort of HIV-1-Exposed Seronegative Individuals VIH-1 HIV-1 Vitamina D Vitamin D Antivirales Antiviral Agents Inmunidad Innata Immunity, Innate HIV Seropositivity Seropositividad para VIH |
| title_short |
High Expression of Antiviral and Vitamin D Pathway Genes are a Natural Characteristic of a Small Cohort of HIV-1-Exposed Seronegative Individuals |
| title_full |
High Expression of Antiviral and Vitamin D Pathway Genes are a Natural Characteristic of a Small Cohort of HIV-1-Exposed Seronegative Individuals |
| title_fullStr |
High Expression of Antiviral and Vitamin D Pathway Genes are a Natural Characteristic of a Small Cohort of HIV-1-Exposed Seronegative Individuals |
| title_full_unstemmed |
High Expression of Antiviral and Vitamin D Pathway Genes are a Natural Characteristic of a Small Cohort of HIV-1-Exposed Seronegative Individuals |
| title_sort |
High Expression of Antiviral and Vitamin D Pathway Genes are a Natural Characteristic of a Small Cohort of HIV-1-Exposed Seronegative Individuals |
| dc.creator.fl_str_mv |
Aguilar Jimenez, Wbeimar Saulle, Irma Trabattoni, Daria Vichi, Francesca Lo Caputo, Sergio Mazzotta, Francesco Rugeles López, María Teresa Biasin, Mara |
| dc.contributor.author.none.fl_str_mv |
Aguilar Jimenez, Wbeimar Saulle, Irma Trabattoni, Daria Vichi, Francesca Lo Caputo, Sergio Mazzotta, Francesco Rugeles López, María Teresa Biasin, Mara |
| dc.contributor.researchgroup.spa.fl_str_mv |
Inmunovirología |
| dc.subject.decs.none.fl_str_mv |
VIH-1 HIV-1 Vitamina D Vitamin D Antivirales Antiviral Agents Inmunidad Innata Immunity, Innate HIV Seropositivity Seropositividad para VIH |
| topic |
VIH-1 HIV-1 Vitamina D Vitamin D Antivirales Antiviral Agents Inmunidad Innata Immunity, Innate HIV Seropositivity Seropositividad para VIH |
| description |
ABSTRACT: Natural resistance to HIV-1 infection is influenced by genetics, viral-exposure, and endogenous immunomodulators such as vitamin D (VitD), being a multifactorial phenomenon that characterizes HIV-1-exposed seronegative individuals (HESNs). We compared mRNA expression of 10 antivirals, 5 immunoregulators, and 3 VitD pathway genes by qRT-PCR in cells of a small cohort of 11 HESNs, 16 healthy-controls (HCs), and 11 seropositives (SPs) at baseline, in response to calcidiol (VitD precursor) and/ or aldithriol-2-(AT2)-inactivated HIV-1. In addition, the expression of TIM-3 on T and NK cells of six HCs after calcidiol and calcitriol (active VitD) treatments was evaluated by flow cytometry. Calcidiol increased the mRNA expression of HAVCR2 (TIM-3; Th1-cells inhibitor) in HCs and HESNs. AT2-HIV-1 increased the mRNA expression of the activating VitD enzyme CYP27B1, of the endogenous antiviral proteins MX2, TRIM22, APOBEC3G, and of immunoregulators ERAP2 and HAVCR2, but reduced the mRNA expression of VitD receptor (VDR) and antiviral peptides PI3 and CAMP in all groups. Remarkably, higher mRNA levels of VDR, CYP27B1, PI3, CAMP, SLPI, and of ERAP2 were found in HESNs compared to HCs either at baseline or after stimuli. Furthermore, calcitriol increases the percentage of CD4+ T cells expressing TIM-3 protein compared to EtOH controls. These results suggest that high mRNA expression of antiviral and VitD pathway genes could be genetically determined in HESNs more than viral-induced at least in peripheral blood mononuclear cells. Moreover, the virus could potentiate bio-activation and use of VitD, maintaining the homeostasis of the immune system. Interestingly, VitD-induced TIM-3 on T cells, a T cell inhibitory and anti-HIV-1 molecule, requires further studies to analyze the functional outcomes during HIV-1 infection. |
| publishDate |
2017 |
| dc.date.issued.none.fl_str_mv |
2017 |
| dc.date.accessioned.none.fl_str_mv |
2023-03-16T22:41:15Z |
| dc.date.available.none.fl_str_mv |
2023-03-16T22:41:15Z |
| dc.type.spa.fl_str_mv |
Artículo de investigación |
| dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| dc.type.redcol.spa.fl_str_mv |
https://purl.org/redcol/resource_type/ART |
| dc.type.coarversion.spa.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.driver.spa.fl_str_mv |
info:eu-repo/semantics/article |
| dc.type.version.spa.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| format |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| status_str |
publishedVersion |
| dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/10495/34081 |
| dc.identifier.doi.none.fl_str_mv |
10.3389/fimmu.2017.00136 |
| dc.identifier.eissn.none.fl_str_mv |
1664-3224 |
| dc.identifier.url.spa.fl_str_mv |
https://www.frontiersin.org/articles/10.3389/fimmu.2017.00136/full |
| url |
https://hdl.handle.net/10495/34081 https://www.frontiersin.org/articles/10.3389/fimmu.2017.00136/full |
| identifier_str_mv |
10.3389/fimmu.2017.00136 1664-3224 |
| dc.language.iso.spa.fl_str_mv |
eng |
| language |
eng |
| dc.relation.ispartofjournalabbrev.spa.fl_str_mv |
Front. Immunol. |
| dc.relation.citationendpage.spa.fl_str_mv |
11 |
| dc.relation.citationissue.spa.fl_str_mv |
136 |
| dc.relation.citationstartpage.spa.fl_str_mv |
1 |
| dc.relation.citationvolume.spa.fl_str_mv |
8 |
| dc.relation.ispartofjournal.spa.fl_str_mv |
Frontiers in Immunology |
| dc.rights.uri.*.fl_str_mv |
http://creativecommons.org/licenses/by/2.5/co/ |
| dc.rights.uri.spa.fl_str_mv |
https://creativecommons.org/licenses/by/4.0/ |
| dc.rights.accessrights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
| dc.rights.coar.spa.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
| rights_invalid_str_mv |
http://creativecommons.org/licenses/by/2.5/co/ https://creativecommons.org/licenses/by/4.0/ http://purl.org/coar/access_right/c_abf2 |
| eu_rights_str_mv |
openAccess |
| dc.format.extent.spa.fl_str_mv |
11 |
| dc.format.mimetype.spa.fl_str_mv |
application/pdf |
| dc.publisher.spa.fl_str_mv |
Frontiers Research Foundation |
| dc.publisher.place.spa.fl_str_mv |
Lausana, Suiza |
| dc.publisher.faculty.spa.fl_str_mv |
sin facultad - programa |
| institution |
Universidad de Antioquia |
| bitstream.url.fl_str_mv |
https://bibliotecadigital.udea.edu.co/bitstreams/d4c1e020-6936-4bf0-8f5d-d56454e5ad7f/download https://bibliotecadigital.udea.edu.co/bitstreams/f3654f25-4fad-486d-ba78-bb71caa358ca/download https://bibliotecadigital.udea.edu.co/bitstreams/fda4d01f-3e76-4502-9985-b41e6330f9db/download https://bibliotecadigital.udea.edu.co/bitstreams/b5a9936c-bf80-41fc-9e04-9b8634288c91/download https://bibliotecadigital.udea.edu.co/bitstreams/f0058c9b-6a7d-4204-86d3-1387c2d36db1/download |
| bitstream.checksum.fl_str_mv |
1646d1f6b96dbbbc38035efc9239ac9c 8a4605be74aa9ea9d79846c1fba20a33 0a8d089b4bd91652d747d4c0f636bcfc 833a2c742750c26fd8c16a42540d37bb 220583b82ccf64562d2fd675f10c6405 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositorio Institucional de la Universidad de Antioquia |
| repository.mail.fl_str_mv |
aplicacionbibliotecadigitalbiblioteca@udea.edu.co |
| _version_ |
1851052159691390976 |
| spelling |
Aguilar Jimenez, WbeimarSaulle, IrmaTrabattoni, DariaVichi, FrancescaLo Caputo, SergioMazzotta, FrancescoRugeles López, María TeresaBiasin, MaraInmunovirología2023-03-16T22:41:15Z2023-03-16T22:41:15Z2017https://hdl.handle.net/10495/3408110.3389/fimmu.2017.001361664-3224https://www.frontiersin.org/articles/10.3389/fimmu.2017.00136/fullABSTRACT: Natural resistance to HIV-1 infection is influenced by genetics, viral-exposure, and endogenous immunomodulators such as vitamin D (VitD), being a multifactorial phenomenon that characterizes HIV-1-exposed seronegative individuals (HESNs). We compared mRNA expression of 10 antivirals, 5 immunoregulators, and 3 VitD pathway genes by qRT-PCR in cells of a small cohort of 11 HESNs, 16 healthy-controls (HCs), and 11 seropositives (SPs) at baseline, in response to calcidiol (VitD precursor) and/ or aldithriol-2-(AT2)-inactivated HIV-1. In addition, the expression of TIM-3 on T and NK cells of six HCs after calcidiol and calcitriol (active VitD) treatments was evaluated by flow cytometry. Calcidiol increased the mRNA expression of HAVCR2 (TIM-3; Th1-cells inhibitor) in HCs and HESNs. AT2-HIV-1 increased the mRNA expression of the activating VitD enzyme CYP27B1, of the endogenous antiviral proteins MX2, TRIM22, APOBEC3G, and of immunoregulators ERAP2 and HAVCR2, but reduced the mRNA expression of VitD receptor (VDR) and antiviral peptides PI3 and CAMP in all groups. Remarkably, higher mRNA levels of VDR, CYP27B1, PI3, CAMP, SLPI, and of ERAP2 were found in HESNs compared to HCs either at baseline or after stimuli. Furthermore, calcitriol increases the percentage of CD4+ T cells expressing TIM-3 protein compared to EtOH controls. These results suggest that high mRNA expression of antiviral and VitD pathway genes could be genetically determined in HESNs more than viral-induced at least in peripheral blood mononuclear cells. Moreover, the virus could potentiate bio-activation and use of VitD, maintaining the homeostasis of the immune system. Interestingly, VitD-induced TIM-3 on T cells, a T cell inhibitory and anti-HIV-1 molecule, requires further studies to analyze the functional outcomes during HIV-1 infection.COL001244411application/pdfengFrontiers Research FoundationLausana, Suizasin facultad - programahttp://creativecommons.org/licenses/by/2.5/co/https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2High Expression of Antiviral and Vitamin D Pathway Genes are a Natural Characteristic of a Small Cohort of HIV-1-Exposed Seronegative IndividualsArtículo de investigaciónhttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionVIH-1HIV-1Vitamina DVitamin DAntiviralesAntiviral AgentsInmunidad InnataImmunity, InnateHIV SeropositivitySeropositividad para VIHFront. Immunol.1113618Frontiers in ImmunologyPublicationCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8927https://bibliotecadigital.udea.edu.co/bitstreams/d4c1e020-6936-4bf0-8f5d-d56454e5ad7f/download1646d1f6b96dbbbc38035efc9239ac9cMD52falseAnonymousREADLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstreams/f3654f25-4fad-486d-ba78-bb71caa358ca/download8a4605be74aa9ea9d79846c1fba20a33MD53falseAnonymousREADORIGINALAguilarWbeimar_2017_HighExpressionAntiviral.pdfAguilarWbeimar_2017_HighExpressionAntiviral.pdfArtículo de investigaciónapplication/pdf3188319https://bibliotecadigital.udea.edu.co/bitstreams/fda4d01f-3e76-4502-9985-b41e6330f9db/download0a8d089b4bd91652d747d4c0f636bcfcMD51trueAnonymousREADTEXTAguilarWbeimar_2017_HighExpressionAntiviral.pdf.txtAguilarWbeimar_2017_HighExpressionAntiviral.pdf.txtExtracted texttext/plain57704https://bibliotecadigital.udea.edu.co/bitstreams/b5a9936c-bf80-41fc-9e04-9b8634288c91/download833a2c742750c26fd8c16a42540d37bbMD56falseAnonymousREADTHUMBNAILAguilarWbeimar_2017_HighExpressionAntiviral.pdf.jpgAguilarWbeimar_2017_HighExpressionAntiviral.pdf.jpgGenerated Thumbnailimage/jpeg14786https://bibliotecadigital.udea.edu.co/bitstreams/f0058c9b-6a7d-4204-86d3-1387c2d36db1/download220583b82ccf64562d2fd675f10c6405MD57falseAnonymousREAD10495/34081oai:bibliotecadigital.udea.edu.co:10495/340812025-03-26 17:52:16.799http://creativecommons.org/licenses/by/2.5/co/open.accesshttps://bibliotecadigital.udea.edu.coRepositorio Institucional de la Universidad de Antioquiaaplicacionbibliotecadigitalbiblioteca@udea.edu.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 |
